Metro-Minnesota Community Oncology Research Consortium — Saint Louis Park, Minnesota

Metro-Minnesota Community Oncology Research Consortium is a clinical research site located in Saint Louis Park, Minnesota, United States 55416.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Metro-Minnesota Community Oncology Research Consortium has participated in 8 clinical trials with 3 currently active.

Therapeutic areas: Clear Cell Renal Cell Carcinoma, Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer, Breast Cancer.

Sponsors: Calithera Biosciences, Inc, Genentech, Inc., Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Metro-Minnesota Community Oncology Research Consortium?

Metro-Minnesota Community Oncology Research Consortium has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Metro-Minnesota Community Oncology Research Consortium conducted?

Metro-Minnesota Community Oncology Research Consortium has 8 clinical trials on record, with 3 currently active. Their work covers Clear Cell Renal Cell Carcinoma, Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer, Breast Cancer.

Is Metro-Minnesota Community Oncology Research Consortium accredited by Crixeo Health?

Yes — Metro-Minnesota Community Oncology Research Consortium holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Metro-Minnesota Community Oncology Research Consortium?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.